FAP and cancer: Recent studies are utilizing this concept by using radiolabeled FAP inhibitors (FAPIs) as tracers for PET imaging and have shown the potential for the detection of both primary tumors and metastasis that were undetectable with 18F-FDG tracers for multiple types of cancers [14,15,16].